sparfloxacin has been researched along with Respiratory Tract Infections in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 16 (88.89) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlén, S; Malmborg, AS | 1 |
| Beumer, H; Hoepelman, AI; Rozenberg-Arska, M; Verhoef, J; Visser, MR | 1 |
| Nakabayashi, M; Niki, Y; Soejima, R; Tamada, S | 1 |
| Braun, S; Juliet, C; Nina, A; Prado, V; Salamanca, L; Trucco, O | 1 |
| Baquero, F; Cantón, R | 1 |
| Rubinstein, E | 1 |
| Aoun, M; Crokaert, F; Duchateau, V; Grenier, P; Klastersky, J; Vandermies, A | 1 |
| Bryson, HM; Goa, KL; Markham, A | 1 |
| Hoogkamp-Korstanje, JA | 1 |
| Ballow, CH; Deinhart, JA; Johnson, DM; Jones, RN; Schentag, JJ | 1 |
| Aguado, AG; Marre, R; Mattina, R; Richard, MP | 1 |
| Domon, H; Miyazaki, S; Yamaguchi, K; Yoshizumi, S | 1 |
| Acusta, A; Dorr, MB; Dowzicky, M; Nadler, H; Talbot, GH | 1 |
| Marre, R; Trautmann, M | 1 |
| Hooper, DC | 2 |
| Fuller, SA; Low, DE; Simor, AE | 1 |
5 review(s) available for sparfloxacin and Respiratory Tract Infections
| Article | Year |
|---|---|
[Significant role of newer quinolone antimicrobials in respiratory tract infection: focused on sparfloxacin].
Topics: Anti-Infective Agents; Bacterial Infections; Fluoroquinolones; Humans; Photosensitivity Disorders; Quinolones; Respiratory Tract Infections | 1994 |
In-vitro activity of sparfloxacin in comparison with currently available antimicrobials against respiratory tract pathogens.
Topics: Anti-Infective Agents; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Quinolones; Respiratory Tract Infections; Streptococcus pneumoniae | 1996 |
Sparfloxacin. A review of its antibacterial activity, pharmacokinetic properties, clinical efficacy and tolerability in lower respiratory tract infections.
Topics: Animals; Anti-Infective Agents; Fluoroquinolones; Humans; Quinolones; Respiratory Tract Infections | 1997 |
New uses for new and old quinolones and the challenge of resistance.
Topics: Anti-Infective Agents; Bacterial Infections; Drug Resistance, Microbial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Piperazines; Respiratory Tract Infections; Sensitivity and Specificity; Sexually Transmitted Diseases; Urinary Tract Infections | 2000 |
The fluoroquinolones after ciprofloxacin and ofloxacin.
Topics: Anti-Infective Agents; Bacterial Infections; Fluoroquinolones; Humans; Naphthyridines; Ofloxacin; Piperazines; Respiratory Tract Infections; Sexually Transmitted Diseases, Bacterial; Skin Diseases, Bacterial; Urinary Tract Infections | 2000 |
2 trial(s) available for sparfloxacin and Respiratory Tract Infections
| Article | Year |
|---|---|
Safety profile of sparfloxacin in the treatment of respiratory tract infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Pneumonia, Bacterial; Quinolones; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 1996 |
Comparison of the in vitro activity of and pathogen responses to sparfloxacin with those of other agents in the treatment of respiratory tract, urinary tract, and skin and skin-structure infections.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Community-Acquired Infections; Fluoroquinolones; Humans; Pneumonia; Respiratory Tract Infections; Skin Diseases, Bacterial; Urinary Tract Infections | 1999 |
11 other study(ies) available for sparfloxacin and Respiratory Tract Infections
| Article | Year |
|---|---|
In vitro activity of sparfloxacin compared with ciprofloxacin and ofloxacin against respiratory tract pathogens.
Topics: Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Respiratory Tract Infections | 1993 |
Changes in adherence of respiratory pathogens to HEp-2 cells induced by subinhibitory concentrations of sparfloxacin, ciprofloxacin, and trimethoprim.
Topics: Anti-Infective Agents; Bacteria; Bacterial Adhesion; Carcinoma; Ciprofloxacin; Fluoroquinolones; Humans; Laryngeal Neoplasms; Quinolones; Respiratory Tract Infections; Trimethoprim; Tumor Cells, Cultured | 1993 |
Sparfloxacin, a new generation fluoroquinolone against S. pneumoniae respiratory infections.
Topics: Animals; Anti-Infective Agents; Fluoroquinolones; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pneumococcal Infections; Quinolones; Respiratory Tract Infections; Streptococcus pneumoniae; Survival | 1995 |
[In vitro comparative activity (E test) of sparfloxacin and other 8 antimicrobial agents against bacteria isolated from patients with respiratory infections acquired in the community].
Topics: Anti-Bacterial Agents; Antitubercular Agents; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; In Vitro Techniques; Quinolones; Respiratory Tract Infections | 1995 |
In vitro activity of trovafloxacin (CP-99,219), sparfloxacin, ciprofloxacin, and fleroxacin against respiratory pathogens.
Topics: Anti-Infective Agents; Ciprofloxacin; Fleroxacin; Fluoroquinolones; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Naphthyridines; Quinolones; Respiratory Tract Infections; Streptococcus pneumoniae | 1996 |
In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections.
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Pefloxacin; Quinolones; Respiratory Tract Infections | 1997 |
Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA. SPAR Study Group.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Bacteria; Drug Resistance, Microbial; Enterobacteriaceae; Fluoroquinolones; Haemophilus; Humans; In Vitro Techniques; Klebsiella; Moraxella catarrhalis; Oxacillin; Quinolones; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae; United States | 1997 |
Sensitivity to sparfloxacin and other antibiotics, of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis strains isolated from adult patients with community-acquired lower respiratory tract infections: a European multicentre study.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Drug Resistance, Microbial; Europe; Fluoroquinolones; Haemophilus influenzae; Humans; Moraxella catarrhalis; Quinolones; Respiratory Tract Infections; Streptococcus pneumoniae | 1998 |
In vivo activity of HSR-903, a new fluoroquinolone, against respiratory pathogens.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Levofloxacin; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Respiratory Tract Infections; Streptococcal Infections; Streptococcus pneumoniae | 1998 |
[Community-acquired respiratory tract infections. Current data on the efficacy of various classes of antibiotics and antibiotic resistance of the main prevalent bacteria species].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Microbial; Erythromycin; Female; Fluoroquinolones; Germany; Haemophilus influenzae; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moraxella catarrhalis; Population Surveillance; Respiratory Tract Infections; Sampling Studies; Streptococcus pneumoniae; Tetracycline | 1999 |
Comparative in vitro activities of sparfloxacin (CI-978; AT-4140) and other antimicrobial agents against staphylococci, enterococci, and respiratory tract pathogens.
Topics: 4-Quinolones; Anti-Bacterial Agents; Fluoroquinolones; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Staphylococcus; Streptococcus | 1990 |